Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Assessment of trabecular bone score, an index of bone microarchitecture, in HIV positive and HIV negative persons within the HIV UPBEAT cohort.

McGinty T, Cotter AG, Sabin CA, Macken A, Kavanagh E, Compston J, Sheehan G, Lambert J, Mallon PWG; HIV UPBEAT (Understanding the Pathology of Bone Diseases in HIV-infected Subjects) Study Group.

PLoS One. 2019 Mar 21;14(3):e0213440. doi: 10.1371/journal.pone.0213440. eCollection 2019.

2.

Proteomic Analysis of the Responses of Candida albicans during Infection of Galleria mellonella Larvae.

Sheehan G, Kavanagh K.

J Fungi (Basel). 2019 Jan 11;5(1). pii: E7. doi: 10.3390/jof5010007.

3.

Exposure to N-chlorotaurine induces oxidative stress responses in Aspergillus fumigatus.

Sheehan G, Nagl M, Kavanagh K.

J Med Microbiol. 2019 Feb;68(2):279-288. doi: 10.1099/jmm.0.000900. Epub 2018 Dec 13.

PMID:
30543319
4.

Innate humoral immune defences in mammals and insects: The same, with differences ?

Sheehan G, Garvey A, Croke M, Kavanagh K.

Virulence. 2018;9(1):1625-1639. doi: 10.1080/21505594.2018.1526531. Review.

PMID:
30257608
5.

The Use of Galleria mellonella Larvae to Identify Novel Antimicrobial Agents against Fungal Species of Medical Interest.

Kavanagh K, Sheehan G.

J Fungi (Basel). 2018 Sep 19;4(3). pii: E113. doi: 10.3390/jof4030113. Review.

6.

Characterisation of the cellular and proteomic response of Galleria mellonella larvae to the development of invasive aspergillosis.

Sheehan G, Clarke G, Kavanagh K.

BMC Microbiol. 2018 Jun 28;18(1):63. doi: 10.1186/s12866-018-1208-6.

7.

The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus.

Sheehan G, Bergsson G, McElvaney NG, Reeves EP, Kavanagh K.

Infect Immun. 2018 Jun 21;86(7). pii: e00097-18. doi: 10.1128/IAI.00097-18. Print 2018 Jul.

8.

Analysis of the early cellular and humoral responses of Galleria mellonella larvae to infection by Candida albicans.

Sheehan G, Kavanagh K.

Virulence. 2018 Jan 1;9(1):163-172. doi: 10.1080/21505594.2017.1370174. Epub 2017 Sep 21.

9.

Extracorporeal membrane oxygenation in an HIV-positive man with severe acute respiratory distress syndrome secondary to pneumocystis and cytomegalovirus pneumonia.

Morley D, Lynam A, Carton E, Martin-Loeches I, Sheehan G, Lynn N, O'Brien S, Mulcahy F.

Int J STD AIDS. 2018 Feb;29(2):198-202. doi: 10.1177/0956462417725447. Epub 2017 Aug 13.

PMID:
28803505
10.

Experience of dolutegravir in HIV-infected treatment-naive patients from a tertiary care University Hospital in Ireland.

Waqas S, O'Connor M, Levey C, Mallon P, Sheehan G, Patel A, Avramovic G, Lambert JS.

SAGE Open Med. 2016 Oct 25;4:2050312116675813. eCollection 2016.

11.

Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015.

Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, Ennis O, O'Donnell K, Keenan E, De Gascun C, Lyons F, Ward M, Danis K, Glynn R, Waters A, Fitzgerald M; outbreak control team.

Euro Surveill. 2015;20(40). doi: 10.2807/1560-7917.ES.2015.20.40.30036.

12.

Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.

Tinago W, Coghlan E, Macken A, McAndrews J, Doak B, Prior-Fuller C, Lambert JS, Sheehan GJ, Mallon PW; Mater Immunology Study Group.

PLoS One. 2014 May 9;9(5):e97011. doi: 10.1371/journal.pone.0097011. eCollection 2014.

13.

Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic.

Sadlier CM, Brown A, Lambert JS, Sheehan G, Mallon PW.

AIDS Res Ther. 2013 Sep 8;10(1):23. doi: 10.1186/1742-6405-10-23.

14.

Predictors of the change in bilirubin levels over twelve weeks of treatment with atazanavir.

Cotter AG, Brown A, Sheehan G, Lambert J, Sabin CA, Mallon PW.

AIDS Res Ther. 2013 May 16;10(1):13. doi: 10.1186/1742-6405-10-13. No abstract available.

15.

Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy.

Satchell CS, O'Halloran JA, Cotter AG, Peace AJ, O'Connor EF, Tedesco AF, Feeney ER, Lambert JS, Sheehan GJ, Kenny D, Mallon PW.

J Infect Dis. 2011 Oct 15;204(8):1202-10. doi: 10.1093/infdis/jir509.

PMID:
21917893
16.

Platelet function and HIV: a case-control study.

Satchell CS, Cotter AG, O'Connor EF, Peace AJ, Tedesco AF, Clare A, Lambert JS, Sheehan GJ, Kenny D, Mallon PW.

AIDS. 2010 Mar 13;24(5):649-57. doi: 10.1097/QAD.0b013e328336098c.

PMID:
20177361
17.

Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.

Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, Gottschalk R, Hemmer R, Maltezou HC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamäki H, Skinhoj P, Ippolito G; EUNID Working Group.

Lancet Infect Dis. 2009 May;9(5):301-11. doi: 10.1016/S1473-3099(09)70070-2.

PMID:
19393960
18.

Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases.

Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G; EUNID Working Group.

Lancet Infect Dis. 2009 Jan;9(1):45-56. doi: 10.1016/S1473-3099(08)70304-9. Review.

PMID:
19095195
19.

Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.

Gallagher DP, Kieran J, Sheehan G, Lambert J, Mahon N, Mallon PW.

Clin Infect Dis. 2008 Aug 1;47(3):e36-8. doi: 10.1086/589869.

PMID:
18558878

Supplemental Content

Loading ...
Support Center